ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo

被引:56
作者
Alonso, Marta M.
Cascallo, Manel
Gomez-Manzano, Candelaria
Jiang, Hong
Bekele, B. Nebiyou
Perez-Gimenez, Anna
Lang, Frederick F.
Piao, Yuji
Alemany, Ramon
Fueyo, Juan
机构
[1] Univ Texas, MD Anderson Canc Ctr, Brain Tumor Ctr, Dept Biostat, Houston, TX 77030 USA
[2] Inst Catal Oncol Barcelona, Translat Res Lab, Barcelona, Spain
关键词
D O I
10.1158/0008-5472.CAN-06-4675
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
During 2007, similar to 200,000 people in the United States will be diagnosed with brain tumors. Gliomas account for 77% of primary malignant brain tumors, and the prognosis has hardly changed in the past 20 years, with only 30% of patients with malignant glioma surviving 5 years after diagnosis. Oncolytic adenoviruses are promising therapies for the treatment of gliomas. Here, report the antiglioma activity of the tumor-selective ICOVIR-5 adenovirus, which encompasses an early 1A adenoviral (E1A) deletion in the retinoblastoma (Rb) protein-binding region, substitution of the E1A promoter for E2F-responsive elements, and an RGD-4C peptide motif inserted into the adenoviral fiber to enhance adenoviral tropism. Mechanistic studies showed a dramatic addiction of ICOVIR-5 to the E2F1 oncogene in vitro and in vivo. This addiction was mediated by the occupancy of the ectopic adeno-Oral E2F1-responsive elements by the endogenous E2F1 protein resulting in high level of E1A expression in cancer cells and potent antiglioma effect. Importantly, we showed for the first time the ability of oncolytic adenoviruses to enhance E2F transcriptional activity in vivo, and we provided direct evidence of the interaction of the E2F1 protein with native and ectopic adenovirus promoters. Restoration of Rb function led to the association of Rb/E2F1 repressor complexes with ICOVIR-5 ectopic E2F1 promoter and subsequent down-modulation of E1A, dramatically impairing adenoviral replication. In xenografted mice, intratumoral injection of ICOVIR-5 resulted in a significant improvement of the median survival (P < 0.0001), and furthermore, led to 37% of long-term survivors free of disease. The antitumor activity of ICOVIR-5 suggests that it has the potential to be an effective agent in the treatment of gliomas.
引用
收藏
页码:8255 / 8263
页数:9
相关论文
共 37 条
[1]   TRANSCRIPTIONAL CONTROL BY E2F [J].
ADAMS, PD ;
KAELIN, WG .
SEMINARS IN CANCER BIOLOGY, 1995, 6 (02) :99-108
[2]   Expression of transcription factor E2F1 and telomerase in glioblastomas: Mechanistic linkage and prognostic significance [J].
Alonso, MM ;
Fueyo, J ;
Shay, JW ;
Aldape, KD ;
Jiang, H ;
Lee, OH ;
Johnson, DG ;
Xu, J ;
Kondo, Y ;
Kanzawa, T ;
Kyo, S ;
Bekele, BN ;
Zhou, X ;
Nigro, J ;
McDonald, JM ;
Yung, WKA ;
Gomez-Manzano, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (21) :1589-1600
[3]   Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus [J].
Berk, AJ .
ONCOGENE, 2005, 24 (52) :7673-7685
[4]  
BERK AJ, 1986, CANCER SURV, V5, P367
[5]   An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism [J].
Dmitriev, I ;
Krasnykh, V ;
Miller, CR ;
Wang, MH ;
Kashentseva, E ;
Mikheeva, G ;
Belousova, N ;
Curiel, DT .
JOURNAL OF VIROLOGY, 1998, 72 (12) :9706-9713
[6]   Xylene-free method for histological preparation:: A multicentre evaluation [J].
Falkeholm, L ;
Grant, CA ;
Magnusson, A ;
Möller, E .
LABORATORY INVESTIGATION, 2001, 81 (09) :1213-1221
[7]   A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo [J].
Fueyo, J ;
Gomez-Manzano, C ;
Alemany, R ;
Lee, PSY ;
McDonnell, TJ ;
Mitlianga, P ;
Shi, YX ;
Levin, VA ;
Yung, WKA ;
Kyritsis, AP .
ONCOGENE, 2000, 19 (01) :2-12
[8]   The functional role of tumor suppressor genes in gliomas - Clues for future therapeutic strategies [J].
Fueyo, J ;
Gomez-Manzano, C ;
Yung, A ;
Kyritsis, AP .
NEUROLOGY, 1998, 51 (05) :1250-1255
[9]   Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway [J].
Fueyo, J ;
Alemany, R ;
Gomez-Manzano, C ;
Fuller, GN ;
Khan, A ;
Conrad, CA ;
Liu, TJ ;
Jiang, H ;
Lemoine, MG ;
Suzuki, K ;
Sawaya, R ;
Curiel, DT ;
Yung, WKA ;
Lang, FF .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (09) :652-660
[10]   Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis [J].
GomezManzano, C ;
Fueyo, J ;
Kyritsis, AP ;
McDonnell, TJ ;
Steck, PA ;
Levin, VA ;
Yung, WKA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (14) :1036-1044